Free tool
Drug Trial Radar: Psychiatry
Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
2
Not yet recruiting, industry sponsors, Psychiatry, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed272
2 trials
Showing 1 to 2, recently updated first.
- Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive DisorderPivotal-lookingNot yet recruiting
Bausch Health Americas, Inc.Industry
NCT02129751 · 246 participants (planned) · Start Jul 1, 2027 · Primary completion Jul 2030
Drug: bupropion hydrobromide; Placebo · For: Major Depressive Disorder
- To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release TabletsPivotal-lookingNot yet recruiting
Luye Pharma Group Ltd.Industry
NCT06426485 · 736 participants (planned) · Start May 30, 2024 · Primary completion Feb 28, 2027
Drug: Toludesvenlafaxine Hydrochloride Sustained-release Tablets; placebo · For: Major Depressive Disorder
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.